HomeNewsTrendsHealthCoronavirus in India: Falling testing numbers, high use of RATs raise fears of missing positive cases: Report

Coronavirus in India: Falling testing numbers, high use of RATs raise fears of missing positive cases: Report

The reason behind the heavy dependency of many states on the rapid antigen tests is the quick test result.

November 20, 2020 / 12:19 IST
Story continues below Advertisement
Representative Image
Representative Image

Amid the surging COVID-19 cases across India, the falling number of daily tests and widespread dependency on rapid antigen tests (RAT) have raised fears that a large number of positive cases could be missed in the country.

An analysis showed that COVID-19 testing has been falling in several states. It has also been found that many states are depending mainly on RAT rather than real-time reverse transcription-polymerase chain reaction (RT-PCR) test, which is considered to be more accurate in detecting the viral infection, reported The Times of India.

Story continues below Advertisement

As per the protocol laid by the Indian Council of Medical Research (ICMR), every positive report for the novel coronavirus infection from RAT can be treated as confirmed. But, the negative reports need to be retested using RT-PCR, the report stated.

However, it is not clear how many states are following the ICMR guidelines of retesting, said the report.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show